# OnCo record domain-therapeutics (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/domain-therapeutics/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "domain-therapeutics" ;
  schema:name "Domain Therapeutics"@en ;
  schema:alternateName "Domain Therapeutics SA"@en ;
  schema:description "Domain Therapeutics develops medicines aimed at a family of cell-surface receptors called GPCRs to help the immune system fight cancer. Its lead antibody removes the immune cells that shield tumours from attack."@en ;
  schema:url <https://onco.cc/companies/domain-therapeutics/>, <https://www.domaintherapeutics.com/> ;
  schema:dateModified "2026-10-29"^^xsd:date ;
  schema:citation <https://www.domaintherapeutics.com/>, <https://www.domaintherapeutics.com/phase-i-ii-trial-dt-7012-targeting-ccr8-solid-tumors/>, <https://clinicaltrials.gov/study/NCT05582850>, <https://clinicaltrials.gov/study/NCT07213882> ;
  schema:addressCountry "FR" ;
  onco:cancers <https://onco.cc/cancers/cutaneous-t-cell-lymphoma/> ;
  onco:sections <https://onco.cc/fronts/immunotherapy/> ;
  onco:technologies <https://onco.cc/technologies/monoclonal-antibody/> ;
  onco:trials <https://onco.cc/trials/nct06819735/> .